|
Benchmark Holdings PLC on Friday said it plans to delist from AIM in London and Euronext Oslo Growth to save costs. The Sheffield, England-based aquaculture biotechnology company cited low liquidity and high costs involved in maintaining the admissions on the exchanges, in relation to the size of its group and remaining operations. The company aims to become a private limited company following the delistings. Benchmark intends to return the vast majority of the net proceeds from the disposal of its Genetics business to shareholders, amounting to £95 million via a combination of a tender offer and a planned special dividend. Through the tender offer alone, it plans to return up to £56.7 million. The company said the tender offer price is for 25 pence per share, which it said is a 48% premium to the ex-cash equity value of the company. Benchmark shares were up 7.3% to 23.60 pence on Friday morning in London, giving the company a market capitalisation of £175.0 million. Benchmark said its remaining operations are Advanced Nutrition and Health, after the disposal of its Genetics business. The company will hold a general meeting on June 18 regarding its plans. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
